ENXTPA:ENGI
ENXTPA:ENGIIntegrated Utilities

How Engie’s (ENXTPA:ENGI) Low‑Income Community Solar Push in Illinois Has Changed Its Investment Story

ENGIE North America recently launched two community solar farms in Knox County, Illinois, supplying renewable power to hundreds of households and businesses while reserving more than 60% of subscriptions for low-to-moderate income customers. A key feature of these projects is the targeted 20% bill reduction for qualifying households, underscoring how community solar can directly address energy affordability as well as decarbonization goals. We’ll now examine how this expansion of low-income...
ENXTPA:SAF
ENXTPA:SAFAerospace & Defense

How Investors May Respond To Safran (ENXTPA:SAF) Expanding Digital Twin Predictive Maintenance With Delta TechOps

In 2024, Delta TechOps announced a collaboration with Safran Electrical & Power to develop advanced maintenance solutions using digital twin technology and predictive maintenance for aircraft power systems, aiming to improve reliability and reduce downtime across airline fleets. This partnership highlights how Safran is embedding data-driven predictive capabilities into its electrical and power offerings, potentially deepening customer relationships as airlines seek higher equipment...
ENXTPA:OVH
ENXTPA:OVHIT

OVH Groupe (ENXTPA:OVH) Valuation Check After Q1 Cloud Growth And AI Expansion Moves

OVH Groupe (ENXTPA:OVH) is back in focus after its first quarter 2026 trading update, reporting organic revenue growth of 6.0% and total revenue of €275.3 million compared with €263.5 million a year earlier. See our latest analysis for OVH Groupe. At a share price of €7.86, OVH Groupe has seen a 9.24% 1 month share price return and a 5.50% year to date share price return. Its 90 day share price return of 32.24% and 3 year total shareholder return of 47.60% indicate that recent momentum...
ENXTPA:TRI
ENXTPA:TRIAuto

Stronger Q1 RV Sales And 2026 Outlook Might Change The Case For Investing In Trigano (ENXTPA:TRI)

Trigano S.A. recently reported unaudited first-quarter sales for the period ended November 30, 2025, of €833.4 million, up from €769.8 million a year earlier, with growth supported by motorhomes, caravans, and mobil-homes. Management also highlighted a planned production ramp-up and a more positive outlook for fiscal 2026, signaling growing confidence in demand across its core recreational vehicle segments. We’ll now examine how the stronger first-quarter sales and planned production ramp-up...
ENXTPA:VIE
ENXTPA:VIEIntegrated Utilities

Should Veolia’s €2.5 Billion Oversubscribed Bond Deal Reshape the Outlook for Veolia Environnement (ENXTPA:VIE) Investors?

In early January 2026, Veolia Environnement completed a record €2.50 billion bond placement across 5-, 8- and 12-year tranches, with fixed coupons between 3.209% and 4.052% and demand peaking at €10.50 billion from more than 570 orders. The high oversubscription, tight pricing versus the secondary market, and the mix of long-dated tranches highlight lenders’ confidence in Veolia’s balance sheet and its ability to fund ecological transformation projects. We’ll now explore how this sizeable,...
ENXTPA:MF
ENXTPA:MFDiversified Financial

How Investors Are Reacting To Wendel (ENXTPA:MF) Spinning Off Stahl’s Leather Chemicals Unit Into Muno

Wendel announced that Stahl has completed the carve-out of its wet-end leather chemicals division, which began operating independently as Muno on 1 January 2026, with Wendel retaining majority ownership of the new company. This move closes Stahl’s multi-year transformation and reshapes Wendel’s portfolio exposure, with Stahl now concentrating on speciality coatings while Muno becomes a separate platform within Wendel’s holdings. We’ll now examine how Wendel’s majority ownership of the newly...
ENXTPA:RNO
ENXTPA:RNOAuto

Why Renault (ENXTPA:RNO) Is Down 7.0% After Margin Concerns Cloud Profitability Outlook – And What's Next

Recently, Renault’s shares moved lower after management comments raised concerns about the company’s profit margins and overall profitability outlook. This reaction highlights how sensitive investors are to any sign that Renault’s margin recovery story may be more challenging than previously thought. We’ll now examine how these renewed worries about Renault’s profit margins may influence the company’s existing investment narrative and risk profile. Trump has pledged to "unleash" American oil...
ENXTPA:GET
ENXTPA:GETInfrastructure

Assessing Getlink (ENXTPA:GET) Valuation After Mixed 2025 Cross Channel Traffic Trends

Getlink (ENXTPA:GET) has just reported December and full year 2025 traffic figures, highlighting lower truck volumes alongside higher passenger vehicle activity. This gives investors fresh data on how its cross Channel business is currently balanced. See our latest analysis for Getlink. Traffic figures and the latest disclosure on Getlink’s 550,000,000 ordinary shares arrive against a share price of €16.45, with a 30 day share price return of 8.72% and a 1 year total shareholder return of...
ENXTPA:GTT
ENXTPA:GTTOil and Gas

A Look At Gaztransport & Technigaz (ENXTPA:GTT) Valuation After New Hanwha Ocean LNG Contract

Gaztransport & Technigaz (ENXTPA:GTT) shares have been in focus after the company announced a new contract with South Korea’s Hanwha Ocean to design cryogenic tanks for seven LNG carriers using its NO96 Super+ system. See our latest analysis for Gaztransport & Technigaz. The Hanwha Ocean contract announcement has coincided with a sharp shift in sentiment, with a 1-day share price return of 5.52% and 7-day share price return of 8.31%. The 1-year total shareholder return of 25.81% and 5-year...
ENXTPA:AM
ENXTPA:AMAerospace & Defense

A Look At Dassault Aviation (ENXTPA:AM) Valuation After Higher 2025 Sales Guidance Above €7b

Dassault Aviation société anonyme (ENXTPA:AM) is in focus after raising its 2025 net sales guidance to over €7b, following 2025 aircraft deliveries that met and slightly exceeded its earlier internal targets. See our latest analysis for Dassault Aviation société anonyme. The raised sales guidance and aircraft delivery update sit against a strong run in the shares, with a 30 day share price return of 13.79% and a 1 year total shareholder return of 51.97%. This suggests momentum has been...
ENXTPA:FRVIA
ENXTPA:FRVIAAuto Components

The Bull Case For Forvia (ENXTPA:FRVIA) Could Change Following Sinopec Capital’s Hydrogen Partnership In China

Forvia has recently announced that Sinopec Capital will take a minority stake in its hydrogen-focused subsidiary, FORVIA Hydrogen Solutions China, through a RMB 300,000,000 (≈ €40,000,000) capital increase, adding an industrial partner across China’s hydrogen value chain. This move gives Forvia a local ally with deep energy and chemical expertise, potentially improving its hydrogen unit’s access to Chinese public and private customers. We’ll now examine how Sinopec Capital’s entry as a local...
ENXTPA:AMUN
ENXTPA:AMUNCapital Markets

Amundi (ENXTPA:AMUN) Valuation Check As CIO Flags Risks In US Tech And AI Stocks

Amundi (ENXTPA:AMUN) is back in focus after chief investment officer Vincent Mortier highlighted risks of excessive valuations in US technology and AI related stocks, explaining that the group is using derivatives to hedge portfolios. See our latest analysis for Amundi. Amundi’s €74.6 share price has recently been supported by stronger short term momentum, with an 11.18% 30 day share price return, while a 28.35% 1 year total shareholder return points to a solid longer term record as investors...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Is It Time To Reassess Sanofi (ENXTPA:SAN) After Recent Share Price Weakness

With Sanofi trading at €84.44, you might be wondering whether the current share price reflects a fair deal or if the market is mispricing the stock. Over the short term, the share price has moved, with a 2.6% return over the last 7 days, 2.1% over the last 30 days, and a 2.6% return year to date, alongside a 7.8% decline over the past year, 4.5% return over 3 years, and 26.2% over 5 years. These mixed returns sit against a backdrop of ongoing interest in large pharmaceutical groups like...